ANXA2 and pancreatic neoplasm: The latter is a hexameric anti-adhesive matrix glycoprotein that interacts with other ECM proteins (fibronectin), surface receptors (annexin A2, cell adhesion integrin) and syndecan membrane proteoglycans all of which are reported to be overexpressed in pancreatic cancer [183,185].